Equity
€103,768 from €533,401 in 2019
Equity fell by 81% in 6 years.
OCULI
Lifetime
9 annual accounts with figures on one time axispeak €1.4m (2025)
€1.4m▲ 13.5%
peak €722,411 (2025)
€722,411▲ 3.8%
peak €533,401 (2019)
€103,768▼ 21.0%
€1.7m▲ 114%
peak 3.6 FTE (2025)
3.6 FTE▲ 5.9%
Board2 names since 2017
2 directors and 1 other
Documentsfilings and deeds
19-03-2026134 days before the deadline
2025abbreviated format
Gross margin from €1.3m to €1.4mDividend €750,000Equity from €131,356 to €103,768Debts from €810,433 to €1.7mInvestments €1.2m
Key points
from the 2025 annual accountsDebts
€1.7m 94% of the balance sheet
Financial debts 49%Suppliers 0%Taxes and wages 1%Other 49%
€1.1m of the debts are secured on the company's own assets. In 2024 that was €66,250.
Securities
€1.0m
Mortgages, new in 2025. 9.6 times equity · not in the 2024 accounts.
Investments
€1.2m 4.5 × depreciation
Green is investment, beige is depreciation.
Filings
9 annual accounts since 2017
The last five annual accounts were filed 33 to 134 days before the end of the period.
Position in the sector
5.7%
Lower solvency than 89% of companies in human health. Sector median 59.4% · 2,807 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as OCULI has now. Each dot stands for 6 companies, two years later.
95.9%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,154 companies, not a prediction for OCULI. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Manager
Manager
- 9,300 sharesdeed of 27-01-2022
- 9,300 sharesdeed of 27-01-2022
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0676410890
Company renamed from OCULIBVovvBVBA to OCULI
“Deuitoefeningvandevolledigemedischeactiviteitdoordearts-aandeelhoudermetinachtnemingvandewettelijkevoorschrift…” (deed in Dutch) · General meeting of 07-09-2023 · Gazette deed
New establishment in Tienen
Oogartsen Veugelen, Leuvenselaan 93
Incorporation
Founding capital of €18,600 · Appointments: (manager) and (manager) · Founder: · Founder: · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| OCULI Lubbeek | €1.8m | €1.4m | 5.7% | 3.6 |
| OOGZORG Dilbeek | €2.1m | €1.3m | 8.4% | 1.8 |
| Antwerpen zuid Kaakchirurgie Edegem | €1.2m | €1.3m | 32.3% | 3.4 |
| Drs. Brijs & Van den Ende Willebroek | €1.8m | €0.9m | 81.7% | 4.8 |
| IMASENO DR VAN WILDER Ham-sur-Heure-Nalinnes | €2.0m | €1.0m | 40.6% | 1.8 |
| Kliniek voor Urologie Hasselt | €2.5m | €1.1m | 1.1% | 7.1 |
| Clinique Vecquée Namur | €2.3m | €1.0m | 63.4% | 3.6 |
These companies have the same main activity as OCULI: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.2m and €2.5m, founded between 2013 and 2021.
Official details
Source: KBO- Status
- Active since 30-05-2017Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Joint committee
- 330.04Health institutions and services · annual accounts 2025
- Establishment units
- 2.264.830.3333210 Lubbeek, since 30-05-2017
- 2.340.199.1353300 Tienen, since 01-01-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 31-10-2023
Annual accounts 2025
- ≈ €1.3mestimated
- €1.8m▲ 94.9%
- Employeeson 31-12-2025
- 5=
- Filing
- Filed on 19-03-2026, 134 days before the end of the filing period
Insights on OCULI
OCULI files the abbreviated format. That format states no turnover. The gross margin rose from €232,309 in 2017 to €1.4m in 2025.
The balance sheet grew most in 2025 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about OCULI
- What is the company number of OCULI?
- The company number of OCULI is 0676.410.890. The VAT number is the same number with BE in front: BE 0676.410.890.
- Where is OCULI based?
- The registered office is at Kruisbooglaan 25, 3210 Lubbeek.Company details
- What does OCULI do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of OCULI?
- OCULI is a private limited company (BV).
- When was OCULI founded?
- OCULI was founded on 30-05-2017.
- Is OCULI still active?
- Yes, OCULI is an active enterprise in the KBO register.
- How many employees does OCULI have?
- OCULI had an average of 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does OCULI fall under?
- In its 2025 annual accounts, OCULI states joint committee 330.04 (Health institutions and services).
- What is the turnover of OCULI?
- The turnover in financial year 2025 is ≈ €1.3m. This figure is estimated from the gross margin of €1.4m and 63 comparable companies (NACE 86). It probably lies between €1.2m and €1.9m.
- Is OCULI profitable?
- In financial year 2025, OCULI made a profit of €722,411.
- Where can I find the annual accounts of OCULI?
- OCULI filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of OCULI due?
- OCULI must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.